RANKL inhibition for giant cell lesions of the jaw: A retrospective cohort analysis.

Saved in:
Bibliographic Details
Title: RANKL inhibition for giant cell lesions of the jaw: A retrospective cohort analysis.
Authors: Schreuder WH; Department of Oral and Maxillofacial Surgery, Amsterdam UMC (Location AMC) and Academic Center for Dentistry, University of Amsterdam, Amsterdam, the Netherlands; Department of Head and Neck Surgery and Oncology, Antoni van Leeuwenhoek/Netherlands Cancer Institute, Amsterdam, the Netherlands. Electronic address: w.h.schreuder@amsterdamumc.nl., Lipplaa A; Department of Medical Oncology, Leiden University Medical Center, Leiden, the Netherlands., Cleven AHG; Department of Pathology, University Medical Center Groningen, Groningen, the Netherlands; Department of Pathology, Leiden University Medical Center, Leiden, the Netherlands., van den Berg H; Department of Pediatric Oncology, Amsterdam University Medical Centers Location AMC, University of Amsterdam, Amsterdam, the Netherlands., Bisschop PH; Department of Endocrinology and Metabolism, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands., de Jongh RT; Department of Internal Medicine, Endocrine section, Amsterdam UMC location Vrije Universiteit Amsterdam, Amsterdam, the Netherlands., Witjes MJH; Department of Oral and Maxillofacial Surgery, University Medical Center Groningen, Groningen, the Netherlands., Kessler PAWH; Department of Cranio-Maxillofacial Surgery, Maastricht University Medical Center, Maastricht, the Netherlands., Merkx MAW; Department of Oral and Maxillofacial Surgery and IQ Healthcare, Radboud University Medical Center, Nijmegen, the Netherlands; Netherlands Comprehensive Cancer Organization, Utrecht, the Netherlands., Edelenbos E; Department of Pediatric Oncology, Amsterdam University Medical Centers Location AMC, University of Amsterdam, Amsterdam, the Netherlands., Klop C; Department of Oral and Maxillofacial Surgery, Amsterdam UMC (Location AMC) and Academic Center for Dentistry, University of Amsterdam, Amsterdam, the Netherlands., Schreurs R; Department of Oral and Maxillofacial Surgery, Amsterdam UMC (Location AMC) and Academic Center for Dentistry, University of Amsterdam, Amsterdam, the Netherlands., Westermann AM; Department of Medical Oncology, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands., Tromp JM; Department of Medical Oncology, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands., Levenga H; Department of Internal Medicine, Groene Hart Ziekenhuis, Gouda, the Netherlands., Gelderblom H; Department of Medical Oncology, Leiden University Medical Center, Leiden, the Netherlands., de Lange J; Department of Oral and Maxillofacial Surgery, Amsterdam UMC (Location AMC) and Academic Center for Dentistry, University of Amsterdam, Amsterdam, the Netherlands.
Source: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2022 Nov; Vol. 175, pp. 263-273. Date of Electronic Publication: 2022 Sep 26.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1879-0852
DOI:10.1016/j.ejca.2022.08.011